mrmainstreet Tuesday, 06/30/20 03:47:33 PM Re: Biobillionair post# 283806 Post # of 290558 My guess would be because approval isn't final yet, and JT hasn't shown his cards on how the company is going to approach that market. Frankly, the market probably feels he might GIA which would be a disaster. So without pivoting to a different topic can you answer my questions? Nothing seems to support your thesis that we're safe from the generics, no matter how many times you post it. Certainly the company would lead with that if it were true, vs. having their stock crash and discussing their own generic.